Drug comparisons
Lasmiditan vs Methysergide
Compare Lasmiditan (Reyvow) vs Methysergide for migraines: acute 5-HT1F treatment vs older prevention with fibrosis risks. Key differences in use and safety.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating acute migraine abortive therapy against historical prophylactic options in patients with frequent attacks.
Bottom line
Lasmiditan is the preferred option for acute treatment while Methysergide is obsolete for prevention due to safety concerns.
All medication comparisons